Treatment of Achalasia with Botox injection
Session
Medicine and Nursing
Description
Achalasia represents the absence of lower esopaheal sphincter relaxation and absence of normal peristalsis of the esophageal body, showed in incidence of 1-2 patients in 100 000 people. Causes of achalasia are of unknown ethiology or secondary causes. It is present equally in men and women, at every age.
Presence of alarm symptoms, such as dysphagia, weight loss, regurgitation, anemia, family history of cancer, warrant further investigation. Specific testing is needed to distinguish achalasia from other disorders. For diagnosis, upper endoscopy, esophagogram, high resolution esophageal manometry are needed. In distinguished cases, abdomen and chest CT scan and pH testing are performed as well. There are several treatment modalities for achalasia. Botulin toxin injection is known since 1995, from Pasricha and Kalloo. Botulin toxin injection is an effective and safe treatment.
Our presentation is a success story and the first injection, in our state, of Botulinum toxin in order to improve the symptomatic dysphagia, in a 73-year-old man, who had cardiopulmonary contraindications for surgery.
Our presentation is a successful story of the injection of Botulinum toxin in order to improve the symptomatic dysphagia, in a 73-year-old man, who had cardiopulmonary contraindications for surgery. Even after 6 months he feels quite well.
Proceedings Editor
Edmond Hajrizi
ISBN
978-9951-550-47-5
Location
UBT Kampus, Lipjan
Start Date
30-10-2021 12:00 AM
End Date
30-10-2021 12:00 AM
DOI
10.33107/ubt-ic.2021.187
Recommended Citation
Gashi, Zaim; Shkololli, Argjira Juniku; and Gashi, Arjeta, "Treatment of Achalasia with Botox injection" (2021). UBT International Conference. 163.
https://knowledgecenter.ubt-uni.net/conference/2021UBTIC/all-events/163
Treatment of Achalasia with Botox injection
UBT Kampus, Lipjan
Achalasia represents the absence of lower esopaheal sphincter relaxation and absence of normal peristalsis of the esophageal body, showed in incidence of 1-2 patients in 100 000 people. Causes of achalasia are of unknown ethiology or secondary causes. It is present equally in men and women, at every age.
Presence of alarm symptoms, such as dysphagia, weight loss, regurgitation, anemia, family history of cancer, warrant further investigation. Specific testing is needed to distinguish achalasia from other disorders. For diagnosis, upper endoscopy, esophagogram, high resolution esophageal manometry are needed. In distinguished cases, abdomen and chest CT scan and pH testing are performed as well. There are several treatment modalities for achalasia. Botulin toxin injection is known since 1995, from Pasricha and Kalloo. Botulin toxin injection is an effective and safe treatment.
Our presentation is a success story and the first injection, in our state, of Botulinum toxin in order to improve the symptomatic dysphagia, in a 73-year-old man, who had cardiopulmonary contraindications for surgery.
Our presentation is a successful story of the injection of Botulinum toxin in order to improve the symptomatic dysphagia, in a 73-year-old man, who had cardiopulmonary contraindications for surgery. Even after 6 months he feels quite well.